Literature DB >> 12006174

Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells.

Jozef Dulak1, Alicja Józkowicz, Roberta Foresti, Aneta Kasza, Matthias Frick, Ihor Huk, Colin J Green, Otmar Pachinger, Franz Weidinger, Roberto Motterlini.   

Abstract

Hypoxia, cytokines, and nitric oxide (NO) stimulate the generation of vascular endothelial growth factor (VEGF) and induce heme oxygenase-1 (HO-1) expression in vascular tissue. HO-1 degrades heme to carbon monoxide (CO), iron, and biliverdin, the latter being reduced to bilirubin by biliverdin reductase. In the present study, we investigated the role of HO-1 in the modulation of VEGF synthesis in rat vascular smooth muscle cells (VSMC). In VSMC stimulated with cytokines, inhibition of NO production significantly, but not completely, reduced VEGF release. In contrast, inhibition of HO activity by tin protoporphyrin IX (SnPPIX) totally prevented cytokine-induced increase in VEGF, despite an augmented synthesis of intracellular NO. Stimulation of HO-1 activity by hemin enhanced VEGF production; this effect was abrogated by blockade of the HO pathway. Similarly, VEGF synthesis induced by hypoxia was down-regulated by SnPPIX, but not by inhibitors of NO synthase. To elucidate further a direct involvement of HO-1 in the observed effects, we generated transfected cells that overexpressed the HO-1 gene. Notably, these cells synthesized significantly more VEGF protein than cells transfected with a control gene. Among the products of HO-1, biliverdin and bilirubin showed no effect, whereas iron ions inhibited VEGF synthesis. Exposure of cells to 1% CO resulted in a marked accumulation of VEGF (20-fold increase) over the basal level. Our data indicate that HO-1 activity influences the generation of VEGF in VSMC in both normoxic and hypoxic conditions. As CO and iron, respectively the inducer and the inhibitor of VEGF synthesis, are concomitantly produced during the degradation of heme, these data indicate that HO by-products may differentially modulate VEGF production.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12006174     DOI: 10.1089/152308602753666280

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  58 in total

1.  DEP induction of ROS in capillary-like endothelial tubes leads to VEGF-A expression.

Authors:  Ming Wei Chao; Iris P Po; Robert J Laumbach; John Koslosky; Keith Cooper; Marion K Gordon
Journal:  Toxicology       Date:  2012-04-07       Impact factor: 4.221

2.  Heme oxygenase-1 induction enhances cell survival and restores contractility to unvascularized three-dimensional adult cardiomyocyte grafts implanted in vivo.

Authors:  Shunsuke Kawamoto; Jerald P Flynn; Qun Shi; Sana W Sakr; Jun Luo; Margaret D Allen
Journal:  Tissue Eng Part A       Date:  2011-03-23       Impact factor: 3.845

3.  Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells.

Authors:  Agnieszka Loboda; Agnieszka Jazwa; Alicja Jozkowicz; Jerzy Dorosz; Jozsef Balla; Grietje Molema; Jozef Dulak
Journal:  Atherosclerosis       Date:  2006-04-18       Impact factor: 5.162

4.  Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratinocytes.

Authors:  Agnieszka Jazwa; Agnieszka Loboda; Slawomir Golda; Jaroslaw Cisowski; Magdalena Szelag; Anna Zagorska; Patrycja Sroczynska; Justyna Drukala; Alicja Jozkowicz; Jozef Dulak
Journal:  Free Radic Biol Med       Date:  2005-12-19       Impact factor: 7.376

Review 5.  Molecular regulation of tumor angiogenesis and perfusion via redox signaling.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

6.  Atorvastatin affects several angiogenic mediators in human endothelial cells.

Authors:  Józef Dulak; Agnieszka Loboda; Agnieszka Jazwa; Anna Zagorska; Jacob Dörler; Hannes Alber; Wolfgang Dichtl; Franz Weidinger; Matthias Frick; Alicja Jozkowicz
Journal:  Endothelium       Date:  2005 Sep-Dec

7.  Heme oxygenase-1-dependent and -independent regulation of angiogenic genes expression: effect of cobalt protoporphyrin and cobalt chloride on VEGF and IL-8 synthesis in human microvascular endothelial cells.

Authors:  A Loboda; A Jazwa; B Wegiel; A Jozkowicz; J Dulak
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2005-09-30       Impact factor: 1.770

8.  Gene expression profiling of the hypoxia signaling pathway in hypoxia-inducible factor 1alpha null mouse embryonic fibroblasts.

Authors:  Ajith Vengellur; Barbara G Woods; Heather E Ryan; Randall S Johnson; John J LaPres
Journal:  Gene Expr       Date:  2003

Review 9.  Heme oxygenase in pregnancy and preeclampsia.

Authors:  Eric M George; Joey P Granger
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-03       Impact factor: 2.894

Review 10.  Heme oxygenase-1 in tumors: is it a false friend?

Authors:  Alicja Jozkowicz; Halina Was; Jozef Dulak
Journal:  Antioxid Redox Signal       Date:  2007-12       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.